Interpretation of WHO consolidated guidelines on tuberculosis: Module 3: diagnosis: tests for tuberculosis infection

doi:10.19982/j.issn.1000-6621.20230128

Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (7): 639-643.doi: 10.19982/j.issn.1000-6621.20230128

• Interpretation of Standards • Previous Articles Next Articles

Interpretation of WHO consolidated guidelines on tuberculosis: Module 3: diagnosis: tests for tuberculosis infection

Xin Henan, Gao Lei()

Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences, Beijing 100730, China

Received:2023-04-21 Online:2023-07-10 Published:2023-06-29
Contact: Gao Lei, Email: gaolei@ipbcams.ac.cn
Supported by:
CAMS Innovation Fund for Medical Sciences(2021-I2M-1-037);National Key R&D Program of China(2022YFC2303202)

Abstract

Abstract:

On September 30, 2022, the World Health Organization (WHO) published the WHO consolidated guidelines on tuberculosis: Module 3: diagnosis: tests for tuberculosis infection. The medical evidence-based guideline systematically evaluated the performance of different tests and recommended using of Mycobacterium tuberculosis antigen-based skin tests for the diagnosis of tuberculosis infection for the first time. The author now introduces the development of the new guideline and interprets the three key recommendations hoping to provide evidence-based reference for tuberculosis infection test and control.

Key words: Tuberculosis, Infection, Diagnosis, differential, Skin tests

CLC Number:

R521
R825.2

Xin Henan, Gao Lei. Interpretation of WHO consolidated guidelines on tuberculosis: Module 3: diagnosis: tests for tuberculosis infection[J]. Chinese Journal of Antituberculosis, 2023, 45(7): 639-643. doi: 10.19982/j.issn.1000-6621.20230128

[1]	World Health Organization. Use of Tuberculosis Interferon-Gamma Release Assays (IGRAs) in Low- and Middle-Income Countries: Policy Statement. Geneva: World Health Organization, 2011.
[2]	World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization, 2018.
[3]	World Health Organization. Use of alternative interferon-gamma release assays for the diagnosis of TB infection: WHO policy statement. Geneva: World Health Organization, 2022.
[4]	World Health Organization. WHO consolidated guidelines on tuberculosis: Module 3: diagnosis: tests for tuberculosis infection. Geneva: World Health Organization, 2022.

[1]	Song Yuanyuan, Xia Hui, Zhao Yanlin. Development process of setting of critical concentrations for phenotypic drug susceptibility testing of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 631-638.
[2]	Cheng Yao, Chen Hongde, Wu Guihui, Lai Min, Luo Haixia, Cui Kunping, Li Yuke. Analysis of death related factors in tuberculosis destroyed lung patients undergoing invasive mechanical ventilation [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 651-657.
[3]	Zheng Rui, Zhao Mingrui, Yang Yuanzheng. Meta-analysis of effectiveness and safety of the cycloserine-containing treatment for multidrug-resistant pulmonary tuberculosis in China [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 658-668.
[4]	Cao Bingsheng, Zhang Gengchen, Fu Liyuan, Wang Jinshan. Application value of ultrasound guided percutaneous biopsy in the diagnosis of hip joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 669-672.
[5]	Wu Yunbiao, Pu Xingyu, Qi Yang, Kou Xianshuai, Xie Wendong, Luo Wenyuan, Liu Shengfen. Comparison of therapeutic effects between calcium sulfate incorporated with rifamycin sodium and autologous bone grafting in the treatment of thoraco-lumbar tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 673-680.
[6]	Zhao Guolian, Lei Qian, Wang Pei, Ren Yunxia, Guan Jing. Value of DNA real-time fluorescence isothermal amplification method and combined testing in early diagnosis of tuberculous pleurisy [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 681-686.
[7]	Zhuo Wenji, Zhang Chenchen, Chen Xunxun, Wei Wenjing, Yu Meiling, Peng Kehao, Xu Liuyue, Chen Yanmei. Analysis of drug resistance characteristics of pulmonary tuberculosis in children in Guangdong, 2014—2020 [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 687-692.
[8]	Zhang Xiaomeng, Li Min, Chai Yinghui, Zhou Jing, Lei Hong. Research progress on the correlation between intestinal microbiota short chain fatty acids and pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 699-706.
[9]	Yang Jun, Deng Qiang, Li Junjie, Wang Yurong, Du Jianqiang, Chen Bo, Zhang Lijuan. Research progress on application of local drug delivery and sustained-release system in spinal tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 707-713.
[10]	Senior Department of Tuberculosis, the th Medical Center of Chinese PLA General Hospital, Editorial Board of Chinese Journal of Antituberculosis, Tuberculosis Control Branch of China Intrnational Exchange and Promotive Association for Medical and Health Care. Expert consensus on the diagnosis and treatment of superficial lymph node tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(6): 531-542.
[11]	Senior Department of Tuberculosis, the th Medical Center of Chinese PLA General Hospital, Editorial Board of Chinese Journal of Antituberculosis, Tuberculosis Control Branch of China Intrnational Exchange and Promotive Association for Medical and Health Care. Expert consensus on the clinical application of nucleic acid MALDI-TOF MS technique in the diagnosis of tuberculosis and non-tuberculosis mycobacteriosis [J]. Chinese Journal of Antituberculosis, 2023, 45(6): 543-558.
[12]	Song Yuanyuan, Xia Hui. Survey on satisfaction of external quality assessment among tuberculosis laboratory network in China [J]. Chinese Journal of Antituberculosis, 2023, 45(6): 559-565.
[13]	He Ping, Wang Yiting, Song Zexuan, Xia Hui, Wang Shengfen, He Wencong, Zheng Yang, Zhao Yanlin. Preliminary study on the gene function of Mycobacterium tuberculosis Rv2333c in macrophages [J]. Chinese Journal of Antituberculosis, 2023, 45(6): 566-574.
[14]	Shang Yaomin, Zhou Xiaolei, Xue Yunling, Leng Xia. Effect of microcard combined with vitamin D on the balance of CD4⁺ T cell subsets in initially treated patients with smear positive pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(6): 575-582.
[15]	Wang Nenhan, Tian Lili, Chen Shuangshuang, Zhao Yanfeng, Fan Ruifang, Chen Hao, Ren Yixuan, Zhang Jie, Yi Junli, Yang Xinyu, Yu Lan, Ding Beichuan, Li Chuanyou, Dai Xiaowei. Study on the detection of rifampicin resistance of Mycobacterium tuberculosis in sputum samples using fluorescence PCR probe melting curve technique [J]. Chinese Journal of Antituberculosis, 2023, 45(6): 583-588.

Interpretation of WHO consolidated guidelines on tuberculosis: Module 3: diagnosis: tests for tuberculosis infection

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 4

Related Articles 15

Recommended Articles

Metrics

Comments